Clinical Trial Update: Open-Label Pilot Study of Guanfacine-Extended Release for the Treatment of Cannabis Dependence [Phase 1]

View source ↗

Summary

This clinical trial update reports results from a Phase 1 open-label pilot study of guanfacine extended-release for cannabis dependence.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Dependence

Drugs mentioned

• Guanfacine Extended Release (guanfacine)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Cannabis Dependence | Phase 1 | Status: COMPLETED | Results posted: 2018-12-12